Cargando…

Influence of vasopressor agent in pediatric septic shock mortality

Detalles Bibliográficos
Autores principales:	Mangia, CMF, Jose, LPS, Monteiro, FL, Fernandes, AT, Biasi, P, Menezes, F, Lima, EL, Oliveira, C, Bueno, F, Paiva, P, Andrade, MC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124166/ http://dx.doi.org/10.1186/cc10164

Ejemplares similares

Adverse events associated with long-term ketamine use in pediatric septic shock
por: Mangia, CMF, et al.
Publicado: (2011)

Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)

Current use of vasopressors in septic shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2019)

Vasopressors in Septic Shock: The Quest for Refinement
por: Pichamuthu, Kishore
Publicado: (2022)

Fluids or vasopressors for the initial resuscitation of septic shock
por: Macdonald, Stephen, et al.
Publicado: (2022)

Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock
por: Ray, David Charles, et al.
Publicado: (2007)

Vasopressors in septic shock: which, when, and how much?
por: Shi, Rui, et al.
Publicado: (2020)

Esophageal and Gastroduodenal Hemorrhagic Necrosis: A Unique Finding in the Setting of Septic Shock and Vasopressor Use
por: Carvão, Joana, et al.
Publicado: (2018)

Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis
por: Avni, Tomer, et al.
Publicado: (2015)

Outcome of patients with septic shock and high-dose vasopressor therapy
por: Auchet, Thomas, et al.
Publicado: (2017)

Should we start vasopressors very early in septic shock?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

Early versus delayed vasopressor administration in patients with septic shock
por: Abe, Toshikazu, et al.
Publicado: (2023)

Broad spectrum vasopressors: a new approach to the initial management of septic shock?
por: Chawla, Lakhmir S., et al.
Publicado: (2019)

Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?
por: Hartemink, Koen J., et al.
Publicado: (2011)

Timing of vasopressor initiation and mortality in septic shock: a cohort study
por: Beck, Vance, et al.
Publicado: (2014)

Vasopressors in septic shock: a systematic review and network meta-analysis
por: Zhou, Feihu, et al.
Publicado: (2015)

Effect of high-dose Ascorbic acid on vasopressor's requirement in septic shock
por: Zabet, Mohadeseh Hosseini, et al.
Publicado: (2016)

Time to vasopressor initiation and organ failure progression in early septic shock
por: Black, Lauren Page, et al.
Publicado: (2020)

Management of Vasopressor-Induced Acute Limb Ischemia (VIALI) in Septic Shock
por: Attallah, Noura, et al.
Publicado: (2022)

The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock
por: Hamzaoui, Olfa, et al.
Publicado: (2023)

Development and performance of a novel vasopressor-driven mortality prediction model in septic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2018)

Using the diastolic shock index to determine when to promptly administer vasopressors in patients with septic shock
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2022)

Mortality rate of vasopressor-dependent septic shock from 1997 through 2006
por: Afessa, B, et al.
Publicado: (2009)

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
por: Sharma, Vinay K, et al.
Publicado: (2003)

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine
por: Vincent, Jean-Louis, et al.
Publicado: (2003)

Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis
por: Bauer, Seth R., et al.
Publicado: (2023)

Is norepinephrine more effective than other vasopressors for septic shock? A systematic review and meta-analysis
por: Zhou, F, et al.
Publicado: (2013)

Septic shock and vasopressor requirement is associated with lower vitamin D levels in critically ill children
por: Madden, K, et al.
Publicado: (2011)

The evaluation of perfusion index as a predictor of vasopressor requirement in patient with sever sepsis and septic shock
por: Rasmy, I, et al.
Publicado: (2015)

Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial
por: Petsakul, Suttasinee, et al.
Publicado: (2020)

Bundle Adherence of Intravenous Antibiotic Fluid Resuscitation and Vasopressor in Children with Severe Sepsis or Septic Shock
por: Barboza, Clarice L, et al.
Publicado: (2020)

Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
por: Kilian, Scott, et al.
Publicado: (2022)

Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review
por: Zhou, Hang-Xiang, et al.
Publicado: (2023)

Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?
por: Carlos Sanchez, E., et al.
Publicado: (2023)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
por: Carr, Anitra C., et al.
Publicado: (2015)

Symmetrical peripheral gangrene of bilateral feet and unilateral hand after administration of vasopressors during septic shock
por: Ruffin, Naeemah, et al.
Publicado: (2018)

Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis
por: Sedhai, Yub Raj, et al.
Publicado: (2022)

Subclinical cardiac dysfunction may impact on fluid and vasopressor administration during early resuscitation of septic shock
por: Murgolo, Francesco, et al.
Publicado: (2023)

Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion
por: Sekino, Motohiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_poss3odcu5p0iemljbgu839gl2